ACCP members Jessica Cottreau, Joyce Lee, and Benjamin Van Tassell were selected by the 2013 ACCP Awards Committee to receive the College’s prestigious 2013 New Educator, New Clinical Practitioner, and New Investigator Awards, respectively. The awards will be presented in Albuquerque, New Mexico, on Monday, October 14, 2013, at 9:15 a.m. during a special session of the 2013 ACCP Annual Meeting.
The ACCP New Educator Award is given to recognize and honor a new educator for outstanding contributions to the discipline of teaching and to the education of health care practitioners. The awardee must have been a Full Member of ACCP at the time of nomination and a member at any level for a minimum of 3 years; in addition, the awardee must have completed his or her terminal training or degree less than 6 years previously. Jessica M. Cottreau, Pharm.D., BCPS, is an assistant clinical professor in the Department of Clinical Sciences and Administration at the University of Houston College of Pharmacy (UHCOP). Dr. Cottreau serves as course coordinator for a required therapeutics course, coordinates a companion clinical skills course, and also teaches in a variety of other courses. She teaches a total of about 200 didactic hours annually, precepts a full cadre of Pharm.D. students, and serves as the residency program director for a PGY2 infectious diseases residency. In addition, Dr. Cottreau has been a leader in curricular innovation and currently serves as chair of the college of pharmacy’s curriculum committee. Her department chair, Kevin Garey, noted in his letter of nomination,
It is immediately evident when you speak with Jessica that she loves to teach. I think because of this, she reaches out for extra duties. Jessica has developed a very popular elective course where she teaches one on one to students who are interested in project management, advanced pharmacy skills, and research. This special problems course has become extremely popular with students. Many students cite this course as the reason why they pursue residency training after pharmacy school.
Elizabeth Coyle, UHCOP Assistant Dean of Assessment, wrote in her letter of support for Dr. Cottreau,
She has implemented a number of thought-provoking and skill-building activities and assessments, including a high stakes oral case presentation. This case presentation has significantly helped the students to be better prepared for their fourth year advanced pharmacy practice experiences, and has been praised by the students as a confidence builder in their case presentation skills. Dr. Cottreau is also involved in numerous other courses throughout the curriculum as a lecturer and lab facilitator. In addition to her didactic success, Dr. Cottreau offers an infectious diseases experiential rotation at St. Luke’s Episcopal Hospital that is always highly sought after by the 4th year students. In the 4½ years she has been at UHCOP, she has received some of the highest marks on her teaching and precepting evaluations. Dr. Cottreau has also had a huge impact on the students outside the classroom, where she is a role-model, listener and leader for the Pharm.D. students. Yearly she mentors a number of students on research projects and poster presentations at local and national meetings.
Dr. Cottreau has been honored as UHCOP Faculty Preceptor of the Year and is a recipient of the Rho Chi Society Teaching Excellence Award and the PLS Faculty Leadership Award. She is also actively engaged in research and scholarship, receiving a CDC grant in 2012 of more than $250,000 for a project focused on regional multidrug-resistant organism prevention and detection. During her short faculty career, she has published regularly in the pharmacy and medical literature. Active in several professional societies, Dr. Cottreau is the current chair of the ACCP Infectious Diseases PRN.
The New Clinical Practitioner Award honors a new clinical practitioner who has made outstanding contributions to the health of patients and/or the practice of clinical pharmacy. The awardee must have been a Full Member of ACCP at the time of nomination, as well as a member at any level for a minimum of 3 years; in addition, the awardee must have completed his or her terminal training or degree less than 6 years previously. Joyce Yu-Chia Lee, Pharm.D., BCPS, BCACP, is an assistant professor of clinical pharmacy in the Department of Pharmacy, Faculty of Science, at the National University of Singapore (NUS) in the Republic of Singapore. She holds a joint appointment as a principal clinical pharmacist at the National Healthcare Group Polyclinics, where she provides direct patient care to those with a wide range of medical problems. Dr. Lee received her Pharm.D. degree from the University of California, San Francisco (UCSF) and completed residency training in ambulatory care at the University of Southern California before assuming her position in Singapore. In Singapore, Dr. Lee launched a successful effort to establish clinical pharmacist involvement in ambulatory care, which she accomplished through two primary means First, she became involved in providing direct patient care in the polyclinics. Second, she developed a training program to develop more clinical pharmacists to fill the growing patient care roles in ambulatory care settings in Singapore. Dr. Alexandre Chan, an associate professor and a colleague of Dr. Lee’s at NUS, wrote in his letter of nomination,
Despite the initial unfamiliarity with the culture and practice in Singapore, Joyce managed to adapt to the health care system quickly and worked towards combating the most insidious disease burden, diabetes mellitus, which inflicts more than 11.3% of patients in Singapore. In October 2007, as part of her joint appointment with the local healthcare institutions, Joyce set up the first pharmacist-managed diabetes clinic, also known as the hypertension, diabetes and lipids clinic (HDL-C) in Singapore. . . . Her clinic started out with a referral rate of just 1-2 patients for the first few sessions. However, as Joyce worked hard to showcase the merits of her clinic in optimizing the drug therapy of patients with uncontrolled diabetes, the referral rate from the physicians increased over time to an average of 10 patients per half-day clinic session. Joyce’s HDL-C has now expanded to 6 primary care institutions and 1 tertiary hospital in Singapore; and she has trained 12 pharmacists to date to run these clinics to care for patients across the island. Furthermore, based on the accumulating positive patient outcomes from her clinics, Joyce was recently awarded with S$1.192 million (equivalent to approximately US$970,000.00) grant from the Singapore Ministry of Health, Health Services Competitive Research Grant to carry out a prospective, multicenter study to evaluate the effectiveness of pharmacist-involved collaborative care model in caring for patients with diabetes in Singapore. This study intends to influence the health policy by mandating the inclusion of pharmacists in every health service for the betterment of patient care.
Lisa Kroon, chair of the Department of Clinical Pharmacy at UCSF, added in her letter of support for Dr. Lee’s nomination,
Dr. Lee is a trailblazer. Upon arriving [in] Singapore, very few pharmacists practiced in the ambulatory care setting. She saw an opportunity to expand the role of pharmacists in this setting, while also meeting the needs of the Ministry of Health to improve the outpatient care of patients with chronic conditions. . . . She created all of the pharmacist protocols and treatment algorithms. Dr. Lee quickly had the vision that practicing pharmacists in this health system needed mentorship and training to not only learn about chronic disease management, as most had experience primarily in the hospital setting, but also about clinic operations and quality improvement. . . . Since a diabetes training program was lacking in Singapore for practicing pharmacists, Dr. Lee developed her own. She brings in an interdisciplinary group of speakers to address diabetes management, using a case-based approach. To date, approximately 150 pharmacists and health care professionals have attended (in a country with less than 2000 pharmacists in total).
Dr. Lee has presented her work at numerous international conferences, including the 2010 Asia-Pacific Conference of the International Society for Pharmacoeconomics and Outcomes, where she received the Best Poster Research Presentation Award. She was also honored as recipient of the 2009–2010 Excellent Young Teacher Award from the Faculty of Science at NUS.
The New Investigator Award recognizes an ACCP member who has made a significant impact on an aspect of clinical pharmaceutical science. The awardee must have been a member of ACCP for more than 3 years; must have completed his or her terminal training or degree less than 6 years previously; and must have a research program with a substantial publication record that includes a programmatic theme or an especially noteworthy single publication. Benjamin W. Van Tassell, Pharm.D., BCPS, is an assistant professor (tenure track) in the Department of Pharmacy at Virginia Commonwealth University and a clinical pharmacist at the Richmond Area Center for High Blood Pressure in Richmond, Virginia. Dr. Van Tassell’s research focuses on immunomodulatory effects in heart failure, with an emphasis on the role of interleukin-1 blockade in the prevention of cardiac remodeling after myocardial infarction. At the time of his nomination, Dr. Van Tassell had published 36 peer-reviewed research papers, 30 of which were submitted since his appointment to the VCU faculty in 2008. His papers have been published in high-impact journals including Circulation Heart Failure, Circulation Research, Journal of the American College of Cardiology, Journal of Cardiovascular Pharmacology, and PLOS ONE. In addition, Dr. Van Tassell is the recipient of a K12 training grant through the VCU Center for Clinical Translational Research. He has served as the principal investigator or coinvestigator for several foundation- and industry-sponsored projects. When nominated, he was also within the funding line as the principal investigator for an R34 NIH-NHLBI grant within a particularly competitive field of submissions. Orly Vardeny, an associate professor of pharmacy and medicine at the University of Wisconsin–Madison, summed up Dr. Van Tassell’s qualifications for the New Investigator Award in her letter supporting his nomination:
Dr. Van Tassell is an exceptionally talented cardiovascular researcher who has already made substantial contributions and is uniquely poised to train a generation of clinical and research pharmacists. His work is already well known and respected in the cardiology community and he is making important and novel contributions in cardiovascular disease. His accomplishments thus far exceed the award criteria of “an ACCP member who has made a major impact on an aspect of clinical pharmaceutical science” and “they must have a research program with a significant publication record having a programmatic theme.” It is difficult to conceive of a more qualified candidate for this award.
Dr. Van Tassell will deliver the annual New Investigator Award Lecture during the October 14 Special Session in Albuquerque.
The members of the 2013 ACCP Awards Committee were Robert MacLaren (chair), M. Shawn McFarland (vice chair), Susan Davis, Stacy Folse, Dwight Kloth, LeAnn Norris, Judith Smith, James Tisdale, and Nathan Wiederhold.